Treatment with mycophenolate mofetil followed by recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes resistant to erythropoietin treatment
Complejo Hospitalario Toledo; Hospital de Cruces Baracaldo (Vizcaya); Hospital Vall d’Hebrón, Barcelona; Hospital Puerta del Mar, Cádiz; Hospital Son Llatzer, Palma de Mallorca, Hospital del Mar, Barcelona, Spain